Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancer.
Dudnik E et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020